Skip to content
Finance Investment, Oil Mining Resources

Ora Gold Limited (ASX:OAU) Achieves Successful Gold Recovery Rates for Crown Prince Metallurgical Testwork

Ora Gold Limited (ASX:OAU) 2 mins read

Perth, Western Australia – WA Gold Explorer, Ora Gold Limited (ASX: OAU) is excited to announce the successful completion of comprehensive metallurgical test work on primary gold mineralisation at its flagship Crown Prince Prospect, located within the expansive Garden Gully Gold Project in the Murchison Goldfield, WA. This test work has not only demonstrated high overall gold recovery rates ranging from 98.2% to 99.8% but also showcased the potential for significant reductions in processing and tailing management costs through optimised cyanide concentration levels.

The Crown Prince Prospect, a high-grade gold deposit, has continued to exhibit strong potential for shallow and easily processable gold mineralisation. Located 22km northwest of Meekatharra, Western Australia, the prospect is a key component of Ora’s strategic exploration and development within the Garden Gully Project.

Following initial positive results from a cyanide leaching program, Ora engaged Independent Metallurgical Operations to further assess the amenability of the gold to gravity concentration and cyanide leach processes. The results have been highly promising:

  • High overall gold recovery rates of 98.2 – 99.8%.
  • Gravity gold recoveries between 66.6 – 90.5%.
  • Rapid leach kinetics, achieving 90% gold recovery within 4 hours across all samples.
  • Reduced cyanide concentration without impacting recovery rates, promising lower operational costs.

Alex Passmore, CEO of Ora Gold, expressed his enthusiasm about the results:

“We are very pleased to report the strong metallurgical performance seen in advance test work from the Crown Prince mineralisation. The results outlined in this release demonstrate that the Crown Prince mineralisation will perform very well in a standard CIL gold processing scenario. The Company is currently drilling along strike and down dip from known mineralisation at Crown Prince to grow the resource which we announced in February 2024. In parallel we are also committed to de-risking the project via building the understanding of the technical parameters required to appropriately evaluate a prospective production scenario. We look forward to updating the market on further exploration results and the progress of technical work as results come to hand.”

With the current gold price remaining robust, these results underscore the economic viability and environmental stewardship of the Crown Prince Prospect. Ora Gold continues to advance its exploration and development efforts, with a keen focus on expanding the resource and further de-risking the project.

Ora Gold is committed to keeping the market updated on its exploration results and technical progress as it unfolds, reinforcing its position as a leader in sustainable and profitable gold mining.


About us:

Ora Gold Limited (ASX:OAU) is a mineral exploration and development company which holds a substantial package of tenements in the prolific Murchison goldfield near Meekatharra, Western Australia.


Contact details:

Jane Morgan

jm@janemorganmanagement.com.au

Media

More from this category

  • Finance Investment, Information Technology
  • 11/04/2024
  • 10:43
Bigtincan Holdings Limited (ASX:BTH)

Bigtincan Holdings (ASX:BTH) – Bigtincan’s AI Investments Pay Off, Achieves Record Q3 Results with Surge in EBITDA and Free Cash Flow

Financial Update (unaudited): Q3 EBITDA of $4.2m (14% margin for the quarter) on operating revenue of $30m. FY24 EBITDA to date of $6.1m and…

  • Contains:
  • Biotechnology, Finance Investment
  • 11/04/2024
  • 10:32
Cleo Diagnostics Limited ASX.COV

CLEO Appoints CRO to Manage U.S. Ovarian Cancer Clinical Trials

Highlights CLEO has appointed U.S.-based Lindus Health to manage U.S. clinical trials for its revolutionary ovarian cancer blood test Lindus Health is a leader in clinical trial management for the med-tech sector, with a strong record of timely and successful trial execution CLEO's U.S. study will prospectively recruit up to 500 patients commencing next month and will verify the performance of CLEO's pre-surgical ovarian cancer test for FDA regulatory approval. ________ MELBOURNE, AUSTRALIA, 11 April 2024: Ovarian cancer diagnostics company, Cleo Diagnostics Limited (ASX:COV) (CLEO, or the Company) is pleased to announce the appointment of international Contract Research Organization (CRO),…

  • Finance Investment, Oil Mining Resources
  • 11/04/2024
  • 10:10
Litchfield Minerals Limited (ASX:LMS)

Litchfield Minerals (ASX:LMS) – Multiple New Chargeability Trends Identified at the Historic Mount Irene Mine

Darwin, Northern Territory – April 10, 2024 – Litchfield Minerals Limited (ASX: LMS) (“Litchfield” or the “Company”), a critical mineral explorer, is excited to…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.